Logo do repositório
 

Boron in medicinal and organic chemistry

dc.contributor.authorPrates, João Lucas Bruno [UNESP]
dc.contributor.authorPavan, Aline Renata [UNESP]
dc.contributor.authorDos Santos, Jean Leandro [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-29T08:36:19Z
dc.date.available2022-04-29T08:36:19Z
dc.date.issued2021-08-01
dc.description.abstractNowadays, boron-containing compounds have gained researchers’ attention because of the wide versatility and applicability of this element in both organic and medicinal chemistry. Since its discovery, its use in medicinal chemistry was neglected because of its possible toxic effects. However, in the past years, boron-containing compounds did not show such effects, and some drugs have already been approved by the Food and Drug Administration to treat diseases, including cancer, infections, and inflammation. Several boroncontaining compounds are used in organic and medicinal chemistry, either as a reagent or therapeutic agent. The chemical properties of this element make its use possible in organic synthesis as a reducing agent and catalyst, mainly in cross-coupling reactions. Among boroncontaining compounds, boranes, azaborines, benzoxaborole, boronic acid, and boron deriva tives are most commonly described. This review article discusses the main properties of boron-containing compounds, their preparation by organic synthesis, as well as their applications in organic synthesis and medicinal chemistry fields, developing new perspectives for further investigations.en
dc.description.affiliationDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP)
dc.description.affiliationInstitute of Chemistry São Paulo State University (UNESP)
dc.description.affiliationUnespDepartment of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP)
dc.description.affiliationUnespInstitute of Chemistry São Paulo State University (UNESP)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdCAPES: 001
dc.description.sponsorshipIdFAPESP: 2018/11079-0
dc.description.sponsorshipIdFAPESP: 2018/195237
dc.description.sponsorshipIdCNPq: 304731/2017-0
dc.format.extent1853-1867
dc.identifierhttp://dx.doi.org/10.2174/1385272825666210625120209
dc.identifier.citationCurrent Organic Chemistry, v. 25, n. 16, p. 1853-1867, 2021.
dc.identifier.doi10.2174/1385272825666210625120209
dc.identifier.issn1385-2728
dc.identifier.scopus2-s2.0-85118948071
dc.identifier.urihttp://hdl.handle.net/11449/229871
dc.language.isoeng
dc.relation.ispartofCurrent Organic Chemistry
dc.sourceScopus
dc.subjectBenzoxaborole
dc.subjectBoron
dc.subjectBoron-containing drugs
dc.subjectBoronic acids
dc.subjectCross-coupling reactions
dc.subjectDrug discovery
dc.subjectMedicinal chemistry
dc.titleBoron in medicinal and organic chemistryen
dc.typeResenhapt
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos